Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azithromycin in Asymptomatic Covid-19 Patients (PHYTCOVID-19)

Sow et al., NCT04501965, PHYTCOVID-19, NCT04501965, Sep 2020

HCQ for COVID-19

1st treatment shown to reduce risk in March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.

No treatment is 100% effective.
Protocols combine treatments.

231 patient HCQ vs. phytomedicines early treatment RCT with results not reported over 6 years after completion.
37 HCQ RCTs have results missing long after expected1-37
The trials report a total of 20,499 patients, with 12 trials having actual enrollment of 3,639, and the remainder estimated.
Sow et al., 30 Sep 2020, Double Blind Randomized Controlled Trial, placebo-controlled, this trial compares with another treatment - results may be better when compared to placebo, trial NCT04501965 (history) (PHYTCOVID-19).